INR 1355.05
(-0.19%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 33.24 Million INR | -37.49% |
2022 | 53.17 Million INR | -6.08% |
2021 | 56.61 Million INR | 249.77% |
2020 | 16.18 Million INR | -20.94% |
2019 | 20.47 Million INR | 362.82% |
2018 | 4.42 Million INR | -98.4% |
2017 | 276.35 Million INR | -11.28% |
2016 | 311.47 Million INR | 53.99% |
2015 | 202.27 Million INR | -32.8% |
2014 | 301.02 Million INR | -28.49% |
2013 | 420.97 Million INR | 11.41% |
2012 | 377.85 Million INR | 2.34% |
2011 | 369.22 Million INR | -21.73% |
2010 | 471.71 Million INR | -14.93% |
2009 | 554.47 Million INR | -4.88% |
2008 | 582.92 Million INR | -1.09% |
2007 | 589.34 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 9.44 Million INR | 0.0% |
2023 Q4 | 33.24 Million INR | 0.0% |
2023 FY | 33.24 Million INR | -37.49% |
2023 Q3 | - INR | -100.0% |
2022 Q4 | 53.17 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 53.17 Million INR | -6.08% |
2022 Q2 | 14.87 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 16.14 Million INR | 0.0% |
2021 Q4 | 56.61 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 FY | 56.61 Million INR | 249.77% |
2020 Q2 | 12.06 Million INR | 0.0% |
2020 Q4 | 16.18 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 FY | 16.18 Million INR | -20.94% |
2019 Q2 | 20.27 Million INR | 0.0% |
2019 FY | 20.47 Million INR | 362.82% |
2019 Q4 | 20.47 Million INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 Q1 | - INR | -100.0% |
2018 Q3 | - INR | -100.0% |
2018 Q4 | 4.42 Million INR | 0.0% |
2018 FY | 4.42 Million INR | -98.4% |
2018 Q1 | - INR | -100.0% |
2018 Q2 | 45.59 Million INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 Q4 | 276.35 Million INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 FY | 276.35 Million INR | -11.28% |
2017 Q2 | 130.98 Million INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 FY | 311.47 Million INR | 53.99% |
2016 Q1 | - INR | -100.0% |
2016 Q4 | 311.47 Million INR | 0.0% |
2016 Q2 | 185.11 Million INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2015 Q4 | 202.27 Million INR | 0.0% |
2015 FY | 202.27 Million INR | -32.8% |
2015 Q2 | 211.9 Million INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2014 Q3 | - INR | -100.0% |
2014 Q2 | 275.62 Million INR | 0.0% |
2014 FY | 301.02 Million INR | -28.49% |
2014 Q4 | 301.02 Million INR | 0.0% |
2013 Q2 | 354.77 Million INR | 0.0% |
2013 Q4 | 420.97 Million INR | 0.0% |
2013 FY | 420.97 Million INR | 11.41% |
2013 Q1 | - INR | -100.0% |
2013 Q3 | - INR | -100.0% |
2012 FY | 377.85 Million INR | 2.34% |
2012 Q4 | 377.85 Million INR | 0.0% |
2012 Q2 | 313.09 Million INR | 0.0% |
2011 FY | 369.22 Million INR | -21.73% |
2011 Q4 | 369.22 Million INR | 0.0% |
2010 FY | 471.71 Million INR | -14.93% |
2009 FY | 554.47 Million INR | -4.88% |
2008 FY | 582.92 Million INR | -1.09% |
2007 FY | 589.34 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Sigachi Industries Limited | 1.43 Billion INR | 97.676% |
Ind-Swift Limited | 10.13 Billion INR | 99.672% |
Bajaj HealthCare Limited | 3.32 Billion INR | 99.001% |
Sakar Healthcare Limited | 793.51 Million INR | 95.811% |
Aurobindo Pharma Limited | 66.47 Billion INR | 99.95% |
Innova Captab Limited | 2.45 Billion INR | 98.644% |
Divi's Laboratories Limited | 30 Million INR | -10.807% |
AstraZeneca Pharma India Limited | 45.98 Million INR | 27.706% |
Morepen Laboratories Limited | 289.99 Million INR | 88.537% |
Mankind Pharma Limited | 2.07 Billion INR | 98.395% |
Sequent Scientific Limited | 4.87 Billion INR | 99.318% |
Wanbury Limited | 1.16 Billion INR | 97.146% |
Laurus Labs Limited | 25.77 Billion INR | 99.871% |
Nectar Lifesciences Limited | 6.35 Billion INR | 99.477% |
Glenmark Life Sciences Limited | 171.48 Million INR | 80.615% |
Alembic Limited | 91.5 Million INR | 63.67% |
Hikal Limited | 8.17 Billion INR | 99.593% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 99.352% |
Neuland Laboratories Limited | 953.89 Million INR | 96.515% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 99.12% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 99.73% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 89.853% |
Themis Medicare Limited | 957.92 Million INR | 96.53% |
RPG Life Sciences Limited | - INR | -Infinity% |
Zydus Lifesciences Limited | 8.04 Billion INR | 99.587% |
Lupin Limited | 29.21 Billion INR | 99.886% |
Amrutanjan Health Care Limited | 17.28 Million INR | -92.339% |
Wockhardt Limited | 23.56 Billion INR | 99.859% |
Vaishali Pharma Limited | 134.91 Million INR | 75.361% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 98.835% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | 62.821% |
Jubilant Pharmova Limited | 36.64 Billion INR | 99.909% |
FDC Limited | 205.18 Million INR | 83.799% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.834% |
Kilitch Drugs (India) Limited | 316.46 Million INR | 89.496% |
Eris Lifesciences Limited | 27.81 Billion INR | 99.88% |
Venus Remedies Limited | 413.3 Million INR | 91.957% |
ZIM Laboratories Limited | 1.08 Billion INR | 96.945% |
Bliss GVS Pharma Limited | 998.4 Million INR | 96.67% |
Par Drugs and Chemicals Limited | - INR | -Infinity% |
Caplin Point Laboratories Limited | 19.7 Million INR | -68.741% |
Shilpa Medicare Limited | 9.37 Billion INR | 99.645% |
Ajanta Pharma Limited | 352.8 Million INR | 90.578% |
Hester Biosciences Limited | 2.44 Billion INR | 98.64% |
Suven Pharmaceuticals Limited | 649.96 Million INR | 94.886% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 99.671% |
Gufic Biosciences Limited | 3.32 Billion INR | 99.001% |
Windlas Biotech Limited | 36.41 Million INR | 8.701% |
Procter & Gamble Health Limited | 95.6 Million INR | 65.228% |
Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | 89.397% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | 96.625% |
Granules India Limited | 13.15 Billion INR | 99.747% |
Aarti Drugs Limited | 5.64 Billion INR | 99.411% |
Bal Pharma Limited | 1.39 Billion INR | 97.62% |
Alkem Laboratories Limited | 14.18 Billion INR | 99.766% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.898% |
Lincoln Pharmaceuticals Limited | 10.66 Million INR | -211.605% |
Medicamen Biotech Limited | 308.17 Million INR | 89.213% |
Unichem Laboratories Limited | 2.47 Billion INR | 98.657% |
Bafna Pharmaceuticals Limited | 243.89 Million INR | 86.37% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -657.393% |
Valiant Laboratories Limited | 767.08 Million INR | 95.666% |
Orchid Pharma Limited | 1.35 Billion INR | 97.541% |
Medico Remedies Limited | 80.5 Million INR | 58.708% |
Ind-Swift Laboratories Limited | 166.21 Million INR | 80.001% |
Ipca Laboratories Limited | 14.38 Billion INR | 99.769% |
Brooks Laboratories Limited | 56.41 Million INR | 41.08% |
Syncom Formulations (India) Limited | 724.86 Million INR | 95.414% |
Piramal Enterprises Limited | 535.85 Billion INR | 99.994% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.917% |
NATCO Pharma Limited | 3.71 Billion INR | 99.104% |
Suven Life Sciences Limited | 7.09 Million INR | -368.395% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 98.281% |
Strides Pharma Science Limited | 25.16 Billion INR | 99.868% |
Indoco Remedies Limited | 6.71 Billion INR | 99.505% |
Alpa Laboratories Limited | 52.46 Million INR | 36.64% |
Lasa Supergenerics Limited | 220.76 Million INR | 84.942% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 94.564% |